Skip to main content
OpenTrials

Clinical trial condition

Smallpox

Explore clinical trials studying Smallpox. Study availability and eligibility vary by location and protocol.

64 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Smallpox trial results

Recruiting

A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa

NCT07379580

Conditions
Animal Diseases, DNA Virus Infections, Infections, +8 more
Locations
  • University of Kinshasa UNIKIN Kinshasa, Democratic Republic of the Congo
  • Institute National de Recherche Biomedicale Kinshasa, Democratic Republic of the Congo
  • TASK Applied Science Cape Town, South Africa
  • TREAD Research Pty Ltd Cape Town, South Africa
View Trial Details
Completed

MVA Post-Event: Administration Timing and Boost Study

NCT00437021

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States
  • University of Maryland, School of Medicine, Center for Vaccine Development and Global Health Baltimore, Maryland, United States
  • Saint Louis University Center for Vaccine Development St Louis, Missouri, United States
  • University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases Rochester, New York, United States
View Trial Details
Completed

A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age

NCT05995275

Conditions
Animal Diseases, DNA Virus Infections, Infections, +7 more
Locations
  • Bradford Teaching Hospitals NHS Foundation Trust Bradford, United Kingdom
  • University Hospitals Bristol and Weston NHS Foundation Trust Bristol, United Kingdom
  • Lakeside Healthcare Research Corby, United Kingdom
  • University Hospitals of Leicester Leicester, United Kingdom
View Trial Details
Completed

High Dose IMVAMUNE® in Vaccinia-Naive Individuals

NCT00879762

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States
  • Saint Louis University Center for Vaccine Development St Louis, Missouri, United States
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days

NCT04971109

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • Clinical Pharmacology of Miami, LLC Miami, Florida, United States
  • Advanced Pharma Miami, Florida, United States
  • Orlando Clinical Research Center Orlando, Florida, United States
  • Meridian Clinical Research Omaha, Nebraska, United States
View Trial Details

Related conditions